HeartHero has announced that its automated external defibrillator (AED) device—known as Elliot—has received CE mark approval. In a press release, the company said that its goal for the device to become the lowest-cost, easiest-to-use, and most portable AED on the market.
HeartHero founder and CEO Gary Montague, said: “Currently there are 86 million people with Cardiac Risk Factors, 12 million of those are high-risk for Cardiac Arrest in the United States alone. It is time that we address those at risk and empower them with a device.”
In February 2020, HeartHero partnered with the American College of Cardiology (ACC), in an alliance that the two organisations said would aim to make a “significant impact” on survival rates after sudden cardiac arrest (SCA).
John Rumsfeld, chief innovation officer at the American College of Cardiology (ACC), said: “There’s a lot of technology out there, but not a lot where you can draw a direct line between a new technology and potentially saving a life. HeartHero’s AED is one of them.”
Following the CE mark approval, HeartHero anticipates that the device will be available for pre-order in Europe in the coming months and is progressing towards the US Food and Drug Administration (FDA) approval process in the USA.